Viewing Study NCT02611804


Ignite Creation Date: 2025-12-24 @ 9:10 PM
Ignite Modification Date: 2026-01-29 @ 5:25 PM
Study NCT ID: NCT02611804
Status: COMPLETED
Last Update Posted: 2017-05-05
First Post: 2015-11-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
Sponsor: Teva Pharmaceuticals USA
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module